These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Community engagement in diverse populations for Alzheimer disease prevention trials. Romero HR; Welsh-Bohmer KA; Gwyther LP; Edmonds HL; Plassman BL; Germain CM; McCart M; Hayden KM; Pieper C; Roses AD Alzheimer Dis Assoc Disord; 2014; 28(3):269-74. PubMed ID: 24614272 [TBL] [Abstract][Full Text] [Related]
28. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ; Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067 [TBL] [Abstract][Full Text] [Related]
29. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD). Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623 [TBL] [Abstract][Full Text] [Related]
30. Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies. Aggarwal R; Sidnam-Mauch E; Neffa-Creech D; Plant A; Williams E; Shami E; Menon U; George S; Langbaum JB J Prev Alzheimers Dis; 2023; 10(4):857-864. PubMed ID: 37874108 [TBL] [Abstract][Full Text] [Related]
31. Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies. Cocroft S; Welsh-Bohmer KA; Plassman BL; Chanti-Ketterl M; Edmonds H; Gwyther L; McCart M; MacDonald H; Potter G; Burke JR Alzheimers Dement; 2020 Aug; 16(8):1107-1114. PubMed ID: 32543781 [TBL] [Abstract][Full Text] [Related]
32. A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research. Esiaka D; Yarborough CC; Fausto BA; Gluck MA Community Health Equity Res Policy; 2024 Jul; 44(4):419-428. PubMed ID: 36120808 [TBL] [Abstract][Full Text] [Related]
33. Using genetics to enable studies on the prevention of Alzheimer's disease. Crenshaw DG; Gottschalk WK; Lutz MW; Grossman I; Saunders AM; Burke JR; Welsh-Bohmer KA; Brannan SK; Burns DK; Roses AD Clin Pharmacol Ther; 2013 Feb; 93(2):177-85. PubMed ID: 23249780 [TBL] [Abstract][Full Text] [Related]
34. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. Reiman EM; Langbaum JB; Fleisher AS; Caselli RJ; Chen K; Ayutyanont N; Quiroz YT; Kosik KS; Lopera F; Tariot PN J Alzheimers Dis; 2011; 26 Suppl 3(Suppl 3):321-9. PubMed ID: 21971471 [TBL] [Abstract][Full Text] [Related]
35. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Bateman RJ; Aisen PS; De Strooper B; Fox NC; Lemere CA; Ringman JM; Salloway S; Sperling RA; Windisch M; Xiong C Alzheimers Res Ther; 2011 Jan; 3(1):1. PubMed ID: 21211070 [TBL] [Abstract][Full Text] [Related]